New PET scan tracer could sharpen detection of liver spread in colorectal cancer

NCT ID NCT06935149

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a new imaging tracer called 18F-PSMA-1007 can better detect liver metastases in people with colorectal cancer. Participants receive an injection of the tracer and then undergo a PET/CT scan. The goal is to see if this method finds the same liver lesions as standard imaging tools like CT or MRI. If it works, it could offer a more precise way to stage cancer and guide treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
18F-PSMA-1007 (a radioactive tracer for PET imaging)
What this could lead to
If successful, this imaging method could help doctors more accurately detect liver metastases in colorectal cancer patients, guiding better treatment decisions.
What could go wrong
This is a very early, small study with only 5 participants, so results may not apply broadly. The tracer may not detect all lesions, and there are risks from radiation exposure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER WITH LIVER METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 833401, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.